“致命尼帕”会全球流行吗？该如何防护？

Core Viewpoint - The Nipah virus, classified as one of the most dangerous pathogens by the World Health Organization, has resurfaced in public attention due to recent outbreaks in India, prompting concerns about a potential global pandemic [1][2]. Group 1: Virus Overview - The Nipah virus, first identified in 1998, has a high mortality rate ranging from 40% to 75%, with some outbreaks reporting a fatality rate of up to 100% [3]. - It primarily affects the central nervous system and respiratory system, with symptoms rapidly progressing from fever and headache to coma within 24 to 48 hours [3]. Group 2: Transmission and Current Situation - The current outbreak in India highlights typical transmission chains, with the initial case linked to a nurse who consumed contaminated date palm sap [5][6]. - The virus can spread from animals to humans, primarily through consumption of food contaminated with bat saliva or urine, and from human to human through close contact, especially in healthcare settings [8]. Group 3: Preparedness and Response - China's public health system has established a multi-layered monitoring and prevention network in response to the Nipah virus, with customs authorities issuing health alerts for travelers from affected regions [11][14]. - The Chinese Center for Disease Control and Prevention has developed guidelines for prevention and control, including laboratory testing and case management [13]. Group 4: Vaccine Development Challenges - Despite the high fatality rate, there are currently no approved vaccines or specific treatments for the Nipah virus due to its sporadic and regional outbreaks, which deter pharmaceutical companies from investing in vaccine development [15]. - Research continues, with some candidate vaccines based on mRNA technology entering clinical trials, and monoclonal antibodies showing potential in compassionate use [15].